Ameriprise’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-107,198
| Closed | -$895K | – | 4050 |
|
|
2021
Q4 | $895K | Buy |
+107,198
| New | +$895K | ﹤0.01% | 3304 |
|
|
2021
Q2 | – | Sell |
-12,000
| Closed | -$123K | – | 3986 |
|
|
2021
Q1 | $123K | Buy |
+12,000
| New | +$123K | ﹤0.01% | 3750 |
|
|
2020
Q4 | – | Sell |
-12,824
| Closed | -$104K | – | 3841 |
|
|
2020
Q3 | $104K | Buy |
+12,824
| New | +$104K | ﹤0.01% | 3633 |
|
|
2018
Q2 | – | Sell |
-177,500
| Closed | -$3.97M | – | 3707 |
|
|
2018
Q1 | $3.97M | Sell |
177,500
-3,566
| -2% | -$79.7K | ﹤0.01% | 2336 |
|
|
2017
Q4 | $2.31M | Sell |
181,066
-3,177
| -2% | -$40.5K | ﹤0.01% | 2584 |
|
|
2017
Q3 | $2.87M | Buy |
184,243
+57,335
| +45% | +$893K | ﹤0.01% | 2426 |
|
|
2017
Q2 | $1.78M | Sell |
126,908
-34,566
| -21% | -$485K | ﹤0.01% | 2665 |
|
|
2017
Q1 | $3.55M | Buy |
+161,474
| New | +$3.55M | ﹤0.01% | 2276 |
|